Embracing Hospicecare Of New Jersey West Llc 109 South Main Street, Suite 23, Cranbury, NJ, 08512 | |
(609) 662-9800 |
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The infrastructure required to support and sustain compliance education and training programs is often decentralized and under-resourced which can hamper program effectiveness within academic health centers, according to Mindy Steinberg, MPH, and Elaine R. Rubin, Ph.D., of the Association of Academic Health Centers, in this month's issue of Academic Medicine.
TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.
› Verified 3 days ago
Name | Embracing Hospicecare Of New Jersey West Llc |
---|---|
Location | 109 South Main Street, Suite 23, Cranbury, New Jersey |
Hospice ID | 311564 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Individual |
Profit Type | FOR PROFIT |
SSA county code | 290 |
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The infrastructure required to support and sustain compliance education and training programs is often decentralized and under-resourced which can hamper program effectiveness within academic health centers, according to Mindy Steinberg, MPH, and Elaine R. Rubin, Ph.D., of the Association of Academic Health Centers, in this month's issue of Academic Medicine.
TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.
› Verified 3 days ago
NPI Number | 1376556704 |
Organization Name | Embracing Hospicecare Of New Jersey West, Llc |
Address | 109 S Main St Cranbury, New Jersey, 08512 |
Phone Number | (609)662-9800 |
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The infrastructure required to support and sustain compliance education and training programs is often decentralized and under-resourced which can hamper program effectiveness within academic health centers, according to Mindy Steinberg, MPH, and Elaine R. Rubin, Ph.D., of the Association of Academic Health Centers, in this month's issue of Academic Medicine.
TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.
› Verified 3 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The infrastructure required to support and sustain compliance education and training programs is often decentralized and under-resourced which can hamper program effectiveness within academic health centers, according to Mindy Steinberg, MPH, and Elaine R. Rubin, Ph.D., of the Association of Academic Health Centers, in this month's issue of Academic Medicine.
TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.
› Verified 3 days ago
Home Health Aides | 1 |
Counselors | 1 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 2 |
Total Employees | 6 |
---|
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The infrastructure required to support and sustain compliance education and training programs is often decentralized and under-resourced which can hamper program effectiveness within academic health centers, according to Mindy Steinberg, MPH, and Elaine R. Rubin, Ph.D., of the Association of Academic Health Centers, in this month's issue of Academic Medicine.
TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.
› Verified 3 days ago
Others | 1 |
Total Volunteers | 1 |
---|
News Archive
A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.
ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.
The infrastructure required to support and sustain compliance education and training programs is often decentralized and under-resourced which can hamper program effectiveness within academic health centers, according to Mindy Steinberg, MPH, and Elaine R. Rubin, Ph.D., of the Association of Academic Health Centers, in this month's issue of Academic Medicine.
TearLab Corporation and COLA, a private, non-profit clinical laboratory education, consultation and accreditation organization, announced today that they have partnered to help make the TearLab™ Osmolarity System available in the U.S. at the point-of-care.
› Verified 3 days ago
Embracing Hospicecare Of New Jersey West Llc Location: 109 South Main Street, Suite 23, Cranbury, New Jersey, 08512 Phone: (609) 662-9800 |